The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Afatinib versus methotrexate as second-line treatment for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) progressing on or after platinum-based therapy: LUX-Head & Neck 3 phase III trial.
 
Ye Guo
Honoraria - Bayer; Celgene; Janssen; Merck Serono; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Merck Serono
 
Myung-Ju Ahn
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; MSD
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; MSD
 
Anthony T. C. Chan
Honoraria - Cullinan Management; Merck Serono; Merck Sharp & Dohme
Consulting or Advisory Role - Merck Sharp & Dohme
Research Funding - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer; Roche
 
Cheng-Hsu Wang
No Relationships to Disclose
 
Jin Hyoung Kang
Honoraria - AstraZeneca; Lilly; Novartis; Ono Pharmaceutical
Consulting or Advisory Role - AstraZeneca; MSD Oncology; Ono Pharmaceutical
Speakers' Bureau - Boehringer Ingelheim; Merck Serono
Research Funding - AstraZeneca; Lilly
 
Sung-Bae Kim
Consulting or Advisory Role - Enzychem Lifesciences (Inst); Lilly (Inst); Novartis (Inst); Odonate Therapeutics (Inst)
Research Funding - Dongkook Pharma (Inst); Genzyme (Inst); Novartis (Inst)
 
Maximino De Guzman Bello
Research Funding - Eisai; Samsung Bioepis
 
Rajendra Singh Arora
No Relationships to Disclose
 
Qingyuan Zhang
No Relationships to Disclose
 
Xiaohui He
No Relationships to Disclose
 
Ping Li
No Relationships to Disclose
 
Arunee Dechaphunkul
Speakers' Bureau - Roche
Travel, Accommodations, Expenses - Eisai
 
Vijay Kumar
No Relationships to Disclose
 
Krishna Kamble
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Alaa Kandil
No Relationships to Disclose
 
Ezra E.W. Cohen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; EMD Serono; Human Longevity, Inc; Incyte; Mavu Pharmaceutical; Merck; Nanobiotix; Pfizer
 
Yuan Geng
Employment - Boehringer Ingelheim
 
Lef Zografos
Employment - Boehringer Ingelheim
 
Ping Zhang Tang
No Relationships to Disclose